Orchard Therapeutics PLC – ADR (NASDAQ:ORTX) And MolMed Extend Their Partnership...
Orchard Therapeutics PLC – ADR (NASDAQ:ORTX) announced last week that it extended its multi-year collaboration with MoIMed as its gene therapy development and manufacturing...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Sorrento Therapeutics Inc. (NASDAQ: SRNE) and China Oncology Focus Commence Enrolment...
Sorrento Therapeutics Inc. (NASDAQ: SRNE) and Lee’s Pharmaceutical Holdings Limited have announced that on July 15, 2021, Lee’s Pharm’s subsidiary China Oncology Focus Limited(COF)...
MAKE IT MODERN
LATEST REVIEWS
Trump is up to his job and saving Wall Street
The texture of the markets feels a bit different today. Stocks gave up all their overnight gains by the open. At first,...
MAKE IT MODERN
PERFORMANCE TRAINING
iBio Inc. (NYSEAMERICAN:IBIO) To Announce Q1 FY2021 Results On November 16, 2020, And Appoints...
iBio Inc. (NYSEAMERICAN:IBIO) has announced that it will report fiscal first-quarter 2021 financial results on November 16, 2020, after the market close.
The company management...
Mersana Therapeutics Inc. (NASDAQ:MRSN) Reports Positive Preliminary Data From Expanded First Phase XMT-1536 Study
Mersana Therapeutics Inc. (NASDAQ:MRSN) reported preliminary safety, efficacy, and tolerability data from its ongoing expansion in the first phase. It evaluates its first antibody-drug...
Sorrento Therapeutics Inc (NASDAQ: SRNE), Receives FDA Nod For Clinical Study of Phase 2...
Sorrento Therapeutics Inc (NASDAQ: SRNE) announced that the company had received the Food and Drug Administration (FDA) green signal, allowing it to go ahead...
NRx Pharmaceuticals (NASDAQ: NRXP) Announce Publication of Aviptadil Study Results In COVID-19 Related Respiratory...
NRx Pharmaceuticals (NASDAQ: NRXP) has published peer-reviewed data from the prospective, open-label, controlled aviptadil study for respiratory failure treatment in patients with Critical coronavirus...
Aditxt Inc (NASDAQ: ADTX) Announces Promising Toxicology Results Confirming ADI-100’s Safety Profile In Human...
Aditxt Inc (NASDAQ: ADTX) has announced that its therapeutic project Adimmune has finalized a toxicology study showing ADI-100's safety profile. ADI-100 is Aditxt’s immunotherapeutic...
MAKE IT MODERN
